Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA)

References

• Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428–1436
   PubMed Web of Science ®Google Scholar
• Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA. Latent autoimmune diabetes mellitus in adults (LADA), the role of antibodies to glutamic acid decarboxilase in diagnosis and prediction of insulin dependency. Diabetes Med 1994; 11: 299–303
   PubMed Web of Science ®Google Scholar
• Shimada A, Imazu Y, Morinaga S, Funae O, Kasuga A, Atsumi Y, Matsuoka K. T cell insulitis found in anti GAD 65+ diabetes with residual β cell function. Diabetes Care 1999; 22: 615–617
   PubMed Web of Science ®Google Scholar
• Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al. A genome -wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130–136
   PubMed Web of Science ®Google Scholar
• Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, Goy JV, Smith AN, Sebag-Montefiore L, Merriman ME, Wilson AJ, Pritchard LE, Cucca F, Barnett AH, Bain SC, Todd JA. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1999; 19: 297–300
   Web of Science ®Google Scholar
• Sanjeevi CB, Falorni A, Kockum I, Hagopian WA, Lernmark A. HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. Diabet Med 1996; 13: 209–217, Review
   PubMed Web of Science ®Google Scholar
• Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, et al. Susceptibility to human type 1 diabetes at IDDM 2 determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284–292
   PubMed Web of Science ®Google Scholar
• Pugliese A, Zeller M, Fernandez A, Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997; 15: 293–297
   PubMed Web of Science ®Google Scholar
• Marron MP, Zeidler A, Raffel LJ, Eckenrode SE, Yang JJ, Hopkins DI, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad JF, Rotter JI, Yang MC, She JX. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 1992; 49: 492–499
   Google Scholar
• Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA. The CTLA4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian diabetes registry. Hum Mol Genet 1996; 5: 1075–1080
   PubMed Web of Science ®Google Scholar
• Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991; 147: 1037–1044
   PubMed Web of Science ®Google Scholar
• Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, Allison JP. The role of CTLA4 in the regulation and initiation of T-cell responses. Immunol Rev 1996; 153: 27–46
   PubMed Web of Science ®Google Scholar
• Donner H, Seidl C, Braun J, Siegmund T, Herwig J, Seifried E, Usadel KH, Badenhoop K. CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families. Diabetes 1998; 47: 1158–1160
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Savost'anov KV, Nosikov VV. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population. BMC Genet. 2001; 2(6), Epub 2001 Mar 27
   PubMedGoogle Scholar
• Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Teng WP, Park Y, Zhang ZX, Goldstein DR, Tao YW, Beaurain G, Tao YW, Bach JF, Huang HS, Luo DF, Zeidler A, Rotter JI, Yang MC, Modilevsky T, Maclaren NK, She JX. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1987; 6: 1275–1282
   Google Scholar
• Murray MG, Thompson WF. Rapid isolation of high molecular—weight plant DNA. Nucleic Acid Res 1980; 8: 4321–4325
   PubMed Web of Science ®Google Scholar
• Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1996; 82: 143–146
   Web of Science ®Google Scholar
• Fajardy I, Vambergue A, Stuckens C, Weill J, Danze PM, Fontaine P. CTLA4 49 A/G dimorphism and type 1 diabetes susceptibility: A French case-control study and segregation analysis. Evidence of a maternal effect. Eur J Immunogenet 2002; 29: 251–257
   PubMedGoogle Scholar
• Yanagawa T, Gomi K, Nakao EI, Inada S. CTLA4 gene polymorphism in Japanese patients with rheumatoid arthritis. J Rheumatol 2000; 27: 2740–2742
   PubMed Web of Science ®Google Scholar
• Seidl C, Donner H, Fischer B, Usadel KH, Seifried E, Kaltwasser JP, Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998; 51: 62–66
   PubMedGoogle Scholar
• Gonzalez-Escribano MF, Rodriguez R, Valenzuela A, Garcia A, Garcia-Lozano JR, Nunez-Roldan A. CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 1999; 53: 296–300
   PubMedGoogle Scholar
• Cosentino A, Gambelunghe G, Tortoioli C, Falorni A. CTLA4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann NY Acad Sci 2002; 958: 337–340
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506–511, Epub 2003 Apr 30
   PubMed Web of Science ®Google Scholar
• Anjos S, Polychronakos C. Mechanisms of genetic susceptibility to type I diabetes: Beyond HLA. Mol Genet Metab 2004; 81: 187–195
   PubMed Web of Science ®Google Scholar
• Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem. 2002; 277: 46478–46486, Epub 2002 Sep 19
   PubMed Web of Science ®Google Scholar
• Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adult. Mol Diagn 2004; 8: 43–49
   PubMedGoogle Scholar
• Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol Pathol 2003; 56: 1–10, Review
   PubMedGoogle Scholar
• Moustakas AK, Papadopoulos GK. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: Keys to the fate of islet beta-cells. Am J Med Genet 2002; 115: 37–47, Review
   PubMed Web of Science ®Google Scholar
• Abe T, Yamaguchi Y, Takino H, Fujita N, Yamauchi-Degawa M, Ozaki M, Yamakawa K, Sera Y, Sakamaki H, Uotani S, Kawasaki E, Awata T, Yamasaki H, Eguchi K. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: Genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody. Diabet Med 2001; 18: 726–731, Sep
   PubMed Web of Science ®Google Scholar
• Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur J Hum Genet 2003; 11: 81–84, Jan
   PubMed Web of Science ®Google Scholar